Structure via PubChem · Public domain (PubChem)
Chemical data
- Formula
- C27H30N4O
- Molecular weight
- 426.6 g/mol
- IUPAC name
- 3-[3-(4-benzhydrylpiperazin-1-yl)propyl]-1H-benzimidazol-2-one
- SMILES
- C1CN(CCN1CCCN2C3=CC=CC=C3NC2=O)C(C4=CC=CC=C4)C5=CC=CC=C5
- InChIKey
- BAINIUMDFURPJM-UHFFFAOYSA-N
- XLogP
- 4.1
- Polar surface area
- 38.8 Ų
- H-bond donors
- 1
- H-bond acceptors
- 3
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
- Indications
- allergic disease, Duchenne muscular dystrophy
via ChEMBL · EBI
Research
248 papers- Oxatomide for stable asthma in adults and children.The Cochrane database of systematic reviews · 2003
- Oxatomide. A review of its pharmacodynamic properties and therapeutic efficacy.Drugs · 1984
- Antiinflammatory effects of oxatomide.Journal of investigational allergology & clinical immunology · 1999
- [Oxatomide: review of pharmacodynamic effects and clinical effects in dermatology].Allergie et immunologie · 1990
- [Protective effect of oxatomide in infantile bronchial asthma. Double-blind study vs placebo].Minerva pediatrica · 1998
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 426.242
Show 4 more facts
- chemical formula
- C₂₇H₃₀N₄O
- canonical SMILES
- C1CN(CCN1CCCN2C3=CC=CC=C3NC2=O)C(C4=CC=CC=C4)C5=CC=CC=C5
- Commons category
- Oxatomide
- defined daily dose
- 60
Sources (3)
via Wikidata · CC0
Gallery (2)
Available in 12 languages
via Wikidata sitelinks · CC0